Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print November 4, 2009, doi:10.1212/WNL.0b013e3181c1e44f)
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
WNL.0b013e3181c1e44fv1
73/20/1616    most recent
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Tremlett, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tremlett, H.
Related Collections
Right arrow Multiple sclerosis
Right arrow Cohort studies
Right arrow Natural history studies (prognosis)
Right arrow Risk factors in epidemiology
Right arrowRelated Article
Received May 21, 2009
Accepted August 18, 2009

Impact of multiple sclerosis relapses on progression diminishes with time

H. Tremlett PhD*, M. Yousefi MSc, V. Devonshire MD, P. Rieckmann MD, Y. Zhao PhD, On behalf of the UBC Neurologists

From the Faculty of Medicine, Division of Neurology (Y.Z.), Multiple Sclerosis Program (H.T., V.D., P.R.), Population and Public Health (H.T.), and Brain Research Centre (H.T., M.Y., P.R.), University of British Columbia, Vancouver, Canada.


* To whom correspondence should be addressed. E-mail: tremlett{at}interchange.ubc.ca.

Objective: The relationship between relapses and long-term disability in multiple sclerosis (MS) remains to be fully elucidated. Current literature is conflicting and focused on early relapses. We investigated the effects of relapses at different stages on disability progression.

Methods: We conducted a retrospective review of 2,477 patients with definite relapsing-onset MS followed until July 2003 in British Columbia, Canada. Time-dependent Cox proportional hazards models examined the effect of relapses at different time periods (0-5; >5-10; >10 years postonset) on time to cane (Expanded Disability Status Scale [EDSS]) and secondary progressive MS (SPMS). Findings were derived from hazard ratios with 95% confidence intervals (CIs), adjusted for sex, onset age, and symptoms.

Results: Mean follow-up was 20.6 years; 11,722 postonset relapses were recorded. An early relapse (within 5 years postonset) was associated with an increased hazard in disease progression over the short term, by 48%; 95% CI 37%-60% for EDSS 6 and 29%; 95% CI 20%-38% for SPMS. However, this substantially lessened to 10%; 95% CI 4%-16% (EDSS 6) and 2%; 95% CI -2%-7% (SPMS) after 10 years postonset. The impact of later relapses (>5-10 years postonset) also lessened over time. Effects were modulated by age, impact being greatest in younger (<25 years at onset) and least in older (≥35 years) patients where relapses beyond 5-years postonset typically failed to reach significance. Relapses during SPMS had no measurable impact on time to EDSS 6 from SPMS.

Conclusion: Relapses within the first 5 years of disease impacted on disease progression over the short term. However, the long-term impact was minimal, either for early or later relapses. Long-term disease progression was least affected by relapses in patients with an extended disease duration (>10 years) or already in the secondary progressive phase.


Related Article

Relapses in multiple sclerosis: Important or not?
Ruth Ann Marrie and Gary Cutter
Neurology 2009 73: 1612-1613. [Full Text] [PDF]



This article has been cited by other articles:


Home page
NeurologyHome page
R. A. Marrie and G. Cutter
Relapses in multiple sclerosis: Important or not?
Neurology, November 17, 2009; 73(20): 1612 - 1613.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by AAN Enterprises, Inc.